Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-20-009754
Filing Date
2020-11-19
Accepted
2020-11-19 13:55:21
Documents
1
Group Members
ABG MANAGEMENT LTD.ALLY BRIDGE MEDALPHA MANAGEMENT GP, LLCALLY BRIDGE MEDALPHA MANAGEMENT L.P.ALLY BRIDGE MEDALPHA MASTER FUND L.P.FAN YU

Document Format Files

Seq Description Document Type Size
1 c11182020sc13g.htm SC 13G 135374
  Complete submission text file 0001214659-20-009754.txt   137294
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90431 | Film No.: 201328307
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022 6468299830
Ally Bridge Group (NY) LLC (Filed by) CIK: 0001822947 (see all company filings)

EIN.: 352593330 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G